New RSV VACCINE available.

Dec 17, 2024
Beyfortus is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease.

Beyfortus is available to all newborns and those <24 months who remain vulnerable to severe RSV disesase in their second RSV season. 

This vaccine was designed to protect newborns and those younger than age 2.  The vaccine is available to be received while your newborn is still in the hospital or at your primary care doctor's office following newborn discharge. 

www.beyfortus.org